Industrial News

AMMEDICS’ K-Biomaterials Technology to attract attention in the Middle East beauty market

AMMEDICS expands sales channel through Korea-UAE Economic Forum

Health & Medical News EN

' Jan. 11. 2024

AMMEDICS, a Korean biomaterials company, to join the January 2023 Korea-United Arab Emirates (UAE) Economic Forum, announced that they had signed a contract with a local buyer in the UAE.

 

Established in 2019, AMMEDICS is a Korean biomaterials specialist that researches and develops biomaterial peptides through biotechnology-based R&D and applies them to manufacture medical devices and cosmetics, including skin booster fillers and dermal fillers.

 

The size of the Middle East beauty market, where Korean biomaterials company AMMEDICS has taken its first step, is worth about tpf=news/view&code=610.3 billion US, and the annual per capita income is ,348. It is a market with high purchasing power, high potential, and investment value.

 

The trend is shifting from color cosmetics were popular in the past to the personal care segment recently, which accounted for the largest share of market revenue at 8.8 million, followed by skincare and cosmetics.

 

AMMEDICS, the Korean Biomaterials Company that also manufactures AQUA SEAL skin booster filler and FILLSYS dermal filler using its proprietary technology and bio-material peptides, confidently expressed that their products would also be well-received in the Middle East beauty market.

 

The contract was signed just three months after they were first introduced to the Middle East through an economic mission. The competitiveness of AMMEDICS’ products in the Middle East beauty market has been confirmed.


  
An official from AMMEDICS said, “Since the Middle East market is very interested in K-beauty, we could also be looking for an opportunity to challenge ourselves,” and upon receiving an email informing them of registration in the Korea-UAE economic forum, he stated, “I was confident that if our products were introduced to the Middle East market, there would definitely be a positive response, so I thought, ‘We must go!’ and applied,” he said, explaining the reason for his participation in the economic forum.

 

The economic forum, which included AMMEDICS, accompanied South Korean President Yoon Sukyeol during his overseas visit in January 2023, was held in the United Arab Emirates and discussed ways to cooperate between companies of the two countries through various events, such as the Korea-UAE Business Forum, and the signing of an economic cooperation MOU in the United Arab Emirates, created opportunities to discuss and build networks.


 

  • Categories : Industrial, Health & Medical News
  • Tags :

Additional Images

Prev Next

Company-Information

CI CI
Company Name AMMEDICS CO., LTD.
Website www.ammedics.imweb.me
Company Overview AMMEDICS Co., Ltd. continues to invest in research and development of biomaterials for cosmetics and pharmaceuticals through R&D based on biotechnology.
Tel +82-2-2135-6477
Company Address 1142, Beoman-ro, Geumcheon-gu, Seoul, Republic of Korea
Share facebook instagram